Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: Better risk assessment with epigenetic markers

Cancer Prevention Research

Volumn 4, Issue 12, 2011, Pages 1982-1992

  Lee, Yi Chia ^a   Wang, Hsiu Po ^a   Wang, Cheng Ping ^a   Ko, Jenq Yuh ^a   Lee, Jang Ming ^a   Chiu, Han Mo ^a   Lin, Jaw Town ^a,c   Yamashita, Satoshi ^d   Oka, Daiji ^d,e   Watanabe, Naoko ^d   Matsuda, Yasunori ^d   Ushijima, Toshikazu ^d   Wu, Ming Shiang ^a,b,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1B; ALDEHYDE DEHYDROGENASE ISOENZYME 1C; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CARCINOGEN; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; METALLOTHIONEIN I; METALLOTHIONEIN IM; NEUROFILAMENT PROTEIN; TRANSCRIPTION FACTOR HOXA9; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BETEL NUT; CANCER PATIENT; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS MUCOSA; EXPOSURE; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROLOGY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 83055167031     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0096     Document Type: Article

References (50)

1. Boyle P, Levin B. World cancer report. Lyon, France: IARC press; 2008.
2. Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010;28:1566-72.
3. Yen AM, Chiu YH, Chen LS, Wu HM, Huang CC, Boucher BJ, et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006;83:1153-60. (Pubitemid 44713118)
4. National Department of Health, Taiwan, Republic of China. Cancer Registry Annual Report 1972-2009.
5. Wei WQ, Abnet CC, Lu N, Roth MJ, Wang GQ, Dye BA, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 2005;54:759-63. (Pubitemid 40732088)
6. Wang WL, Lee CT, Lee YC, Hwang TZ, Wang CC, Hwang JC, et al. Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck 2011;33:77-81.
7. Park SL, Lee YC, Marron M, Agudo A, Ahrens W, Barzan L, et al. The association between change in body mass index and upper aerodigestive tract cancers in the ARCAGE project: Multicenter case-control study. Int J Cancer 2011;128:1449-61.
8. Lee CH, Lee JM, Wu DC, Hsu HK, Kao EL, Huang HL, et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 2005;113:475-82. (Pubitemid 40038718)
9. Ishiguro S, Sasazuki S, Inoue M, Kurahashi N, Iwasaki M, Tsugane S. JPHC Study Group. Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett 2009;275:240-6.
10. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 2004;159:1-16. (Pubitemid 38049416)
11. Lee CH, Lee JM, Wu DC, Goan YG, Chou SH, Wu IC, et al. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer 2008;122:1347-56. (Pubitemid 351287236)
12. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 2009;137:1768-75.
13. Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 2010;59:1457-64.
14. Lee JM, Lee YC, Yang SY, Shi WL, Lee CJ, Luh SP, et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000;89:458-64.
15. Yokoyama A, Yokoyama T, Muramatsu T, Omori T, Matsushita S, Higuchi S, et al. Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men. Carcinogenesis 2003;24:1773-8. (Pubitemid 37408140)
16. Wu DC, Wu IC, Lee JM, Hsu HK, Kao EL, Chou SH, et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 2005;100:588-93.
17. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, et al. Australian Cancer Study. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010;139:73-83.
18. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, KochWM,et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
19. Muto M, Hironaka S, Nakane M, Boku N, Ohtsu A, Yoshida S. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 2002;56:517-21.
20. Yokoyama T, Yokoyama A, Kumagai Y, Omori T, Kato H, Igaki H, et al. Health risk appraisal models for mass screening of esophageal cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2008;17:2846-54.
21. Muto M, Nakane M, Hitomi Y, Yoshida S, Sasaki S, Ohtsu A, et al. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer. Carcinogenesis 2002;23:1759-65. (Pubitemid 35214963)
22. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010;60:376-92.
23. Nakajima T, Enomoto S, Ushijima T. DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med 2008;13:8-15.
24. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-Part 1: Epidemiology, presentation, and prevention. BMJ 2010;341:c4684.
25. Chung CS, Lee YC, Wang CP, Ko JY, Wang WL, Wu MS, et al. Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent. J Formos Med Assoc 2010;109:408-21.
26. Liou JM, Lin JT, Wang HP, Huang SP, Lee YC, Chiu HM, et al. IL-1B-511 C->T polymorphism is associated with increased host susceptibility to Helicobacter pylori infection in Chinese. Helicobacter 2007;12:142-9.
27. Chen CJ, Viscidi RP, Chuang CH, Huang YC, Chiu CH, Lin TY. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination. J Clin Virol 2007;38:126-30. (Pubitemid 46091844)
28. Lee YC, Wang CP, Chen CC, Chiu HM, Ko JY, Lou PJ, et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest Endosc 2009;69:408-17.
29. Wang CP, Lee YC, Yang TL, Lou PJ, Ko JY. Application of unsedated transnasal esophagogastroduodenoscopy in the diagnosis of hypopharyngeal cancer. Head Neck 2009;31:153-7.
30. Oka D, Yamashita S, Tomioka T, Nakanishi Y,Kato H,Kaminishi M, et al. The presence of aberrantDNAmethylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009;115:3412-26.
31. Gönen M. Comparison and covariate adjustment of ROC curves. In: Gönen M, editor. Analyzing receiver operating characteristic curves with SAS. Cary, NC: SAS Institute Inc.; 2007. p. 37-52.
32. Chen KN, Gu ZD, Ke Y, Li JY, Shi XT, Xu GW. Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Clin Cancer Res 2005;11:1044-9. (Pubitemid 40175752)
33. Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, et al. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 2010;5:e9003.
34. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, et al. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 2005;65:4963-8. (Pubitemid 40740837)
35. Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, et al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 2008;48:508-18.
36. Hishikawa Y, Koji T, Dhar DK, Kinugasa S, Yamaguchi M, Nagasue N. Metallothionein expression correlateswith metastatic and proliferative potential in squamous cell carcinoma of the oesophagus. Br J Cancer 1999;81:712-20. (Pubitemid 29458871)
37. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007;5:1413-7, 1417.e1-2.
38. Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010;127:93-100.
39. Reid BJ. Cancer risk assessment and cancer prevention: promises and challenges. Cancer Prev Res 2008;1:229-32.
40. Paun BC, Kukuruga D, Jin Z, Mori Y, Cheng Y, Duncan M, et al. Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. Cancer 2010;116:4495-501.
41. Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, et al. Association between folate levels and CpG island hypermethylation in normal colorectal mucosa. Cancer Prev Res 2010;3:1552-64.
42. Roth MJ, Hu N, Emmert-Buck MR, Wang QH, Dawsey SM, Li G, et al. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res 2001;61:4098-104. (Pubitemid 32720977)
43. van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86. (Pubitemid 35447001)
44. Roth MJ, Abnet CC, Hu N, Wang QH, Wei WQ, Green L, et al. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep 2006;15:1591-7.
45. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res 2006;12:4515-22. (Pubitemid 44297800)
46. Ishii T, Murakami J, Notohara K, Cullings HM, Sasamoto H, Kambara T, et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut 2007;56:13-9.
47. Adams L, Roth MJ, Abnet CC, Dawsey SP, Qiao YL, Wang GQ, et al. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res 2008;1:357-61.
48. Chen H, Sukumar S. HOXgenes: emerging stars in cancer. Cancer Biol Ther 2003;2:524-5.
49. Yamashita S, Hosoya K, Gyobu K, Takeshima H, Ushijima T. Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis. DNA Re 2009;16:275-86.
50. Ulrich CM, Grady WM. Linking epidemiology to epigenomics-where are we today? Cancer Prev Res 2010;3:1505-8.